H.C. Wainwright’s $5 target on FHTX

FHTX Foghorn Therapeutics Inc

$2.02 → $5 (+148%) by Oct 2027

Buy · lowers · said Oct 2, 2026 · 12-month default horizon

Open: judged on the close on Oct 2, 2027

The article this target came from

Foghorn Therapeutics stock price target cut to $5 by H.C. Wainwright on program halt

Investing.com · Oct 2, 2026

H.C. Wainwright lowered its price target on Foghorn Therapeutics Inc. to $5.00 from $13.00 while maintaining a Buy rating

H.C. Wainwright’s track record → Foghorn Therapeutics Inc →

A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.